These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15354946)

  • 1. QT dispersion estimated from 80 body surface potential map leads and from standard 12-leads ECG in psychiatric patients treated with dosulepin.
    Havránek S; Micek M; Paclt I; Slavícek J; Kittnar O; Dohnalová A; Brizman E; Hála P; Kittzlerová E; Pisvejcová K
    Prague Med Rep; 2004; 105(1):53-63. PubMed ID: 15354946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QT dispersion and electrical heart field morphology in patients treated with dosulepin.
    Kittnar O; Paclt I; Mlcek M; Slavícek J; Dohnalová A; Havránek S; Brizman E; Kitzlerová E; Pisvejcová K
    Physiol Res; 2004; 53(4):379-86. PubMed ID: 15311996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dispersion of QT intervals--a myth or a diagnostic symptom?].
    Kittnar O; Mlcek M
    Cas Lek Cesk; 2004; 143(9):604-7. PubMed ID: 15532899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance of the mathematical model of cardiac electrical field for the interpretation of experimental data].
    Mlcek M; Kittnar O
    Cas Lek Cesk; 2004; 143(9):608-13. PubMed ID: 15532900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrocardiographic dose-dependent changes in prophylactic doses of dosulepine, lithium and citalopram.
    Paclt I; Slavícek J; Dohnalová A; Kitzlerová E; Pisvejcová K
    Physiol Res; 2003; 52(3):311-7. PubMed ID: 12790762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels of dosulepine and heart electric field.
    Kitzlerová E; Slavícek J; Pisvejcová K; Anders M; Dohnalová A; Balíková M
    Physiol Res; 2003; 52(3):319-25. PubMed ID: 12790763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of slow coronary flow on electrocardiographic parameters reflecting ventricular heterogeneity.
    Sezgin AT; Barutcu I; Ozdemir R; Gullu H; Topal E; Esen AM; Tandogan I; Acikgoz N
    Angiology; 2007; 58(3):289-94. PubMed ID: 17626982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescribing of venlafaxine and dosulepin in primary care.
    McAllister-Williams RH; Foran K; Forrest S; Ingram G; McMahon L; Taylor M; Rajwal MS; Cornwall PL
    J Psychopharmacol; 2006 Nov; 20(6):868. PubMed ID: 17060347
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of the antidepressant effects of venlafaxine and dosulepin in a naturalistic setting.
    Bukh JD; Jørgensen MB; Dam H; Plenge P
    Nord J Psychiatry; 2009; 63(4):347-51. PubMed ID: 19347769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of the QT interval dispersion after aortic valve replacement reflects changes in electrical function rather than structural remodeling.
    Orlowska-Baranowska E; Baranowski R; Kusmierczyk B; Sepiska J
    J Heart Valve Dis; 2005 Mar; 14(2):181-5. PubMed ID: 15792177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic value of QT dispersion for acute coronary syndrome in patients presenting with chest pain and nondiagnostic initial electrocardiograms.
    Pekdemir M; Karaca I; Cevik Y; Yanturali S; Ilkay E
    Mt Sinai J Med; 2006 Sep; 73(5):813-7. PubMed ID: 17008945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of arsenic trioxide on QT interval prolongation during APL therapy.
    Zhou J; Meng R; Li X; Lu C; Fan S; Yang B
    Chin Med J (Engl); 2003 Nov; 116(11):1764-6. PubMed ID: 14642155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abuse of dosulepin to induce mania.
    Lepping P; Menkes DB
    Addiction; 2007 Jul; 102(7):1166-7. PubMed ID: 17567406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of maximum corrected QT and corrected QT dispersion in electrocardiography after kidney transplantation.
    Monfared A; Ghods AJ
    Iran J Kidney Dis; 2008 Apr; 2(2):95-8. PubMed ID: 19377216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QT interval analysis in patients with chronic liver disease: a prospective study.
    Kosar F; Ates F; Sahin I; Karincaoglu M; Yildirim B
    Angiology; 2007; 58(2):218-24. PubMed ID: 17495272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QT-interval dispersion in type 2 diabetic and non-diabetic patients with post-myocardial infarction.
    Sakabe K; Fukuda N; Fukuda Y; Wakayama K; Nada T; Morishita S; Shinohara H; Tamura Y
    Nutr Metab Cardiovasc Dis; 2008 Feb; 18(2):121-6. PubMed ID: 17346952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of epirubicin-based chemotherapy and dexrazoxane supplementation on QT dispersion in non-Hodgkin lymphoma patients.
    Galetta F; Franzoni F; Cervetti G; Cecconi N; Carpi A; Petrini M; Santoro G
    Biomed Pharmacother; 2005 Dec; 59(10):541-4. PubMed ID: 16325366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in QT dispersion after thrombolysis for stroke.
    Lazar J; Busch D; Wirkowski E; Clark LT; Salciccioli L
    Int J Cardiol; 2008 Apr; 125(2):258-62. PubMed ID: 17509702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the electrocardiographic effect of dothiepin and amitriptyline.
    Claghorn JL; Schroeder J; Goldstein BJ
    J Clin Psychiatry; 1984 Jul; 45(7):291-3. PubMed ID: 6376479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QT dispersion increases during intubation in patients with coronary artery disease.
    Ay B; Fak AS; Toprak A; Göğüş YF; Oktay A
    J Electrocardiol; 2003 Apr; 36(2):99-104. PubMed ID: 12764691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.